Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Low viral load in hepatitis C treatment: Is a third drug necessary?

When resources for hepatitis C treatment with new directly acting antivirals are limited, findings from the United States suggest that previously untreated people with low viral loads

Published
23 November 2012
By
Rob Camp
Tenofovir safe and effective for long-term hepatitis B treatment with little bone loss

Tenofovir (Viread) continues to be safe and effective for treating chronic hepatitis B through eight years of follow-up, researchers reported at The Liver Meeting 2012, the 63rd

Published
22 November 2012
By
Liz Highleyman
Sofosbuvir and daclatasvir dual regimen cures most people with HCV genotypes 1, 2, or 3

A 12-week, once-daily regimen of the hepatitis C (HCV) polymerase inhibitor sofosbuvir and the NS5A inhibitor daclatasvir, without interferon or ribavirin, produced sustained virological response rates for treatment-naive people

Published
21 November 2012
By
Liz Highleyman
Interferon-free hepatitis C treatment with faldaprevir proves safe and effective in people with cirrhosis

The first major data on interferon-free hepatitis C treatment in people with cirrhosis show that treatment using BI-201335 – now known as faldaprevir – and BI-207127 with

Published
20 November 2012
By
Keith Alcorn
Pakistan: Hepatitis C treatment: Produce cheap injections immediately, orders PAC

A Public Accounts Committee (PAC) panel has ordered that the production of low-cost interferon injections, aimed at curing Hepatitis C, be started immediately. The order follows a National Accountability Bureau (NAB) inquiry into why the process has been continuously delayed over the last few years.

Published
20 November 2012
From
The Express Tribune
Simeprevir is safe and effective with interferon/ribavirin for hepatitis C patients with cirrhosis

The hepatitis C protease inhibitor simeprevir (formerly TMC435) was generally safe and well tolerated in people with advanced liver fibrosis or cirrhosis and improved sustained response rates

Published
19 November 2012
By
Liz Highleyman
FDA panel wants more info about hep B vaccine

An FDA advisory committee voted 13-1 in support of the efficacy of a hepatitis B vaccine on Thursday but questioned its safety and lack of information on its effects among certain minorities.

Published
19 November 2012
From
MedPage Today
Copy of FDA panel wants more info about hep B vaccine

An FDA advisory committee voted 13-1 in support of the efficacy of a hepatitis B vaccine on Thursday but questioned its safety and lack of information on its effects among certain minorities.

Published
19 November 2012
From
MedPage Today
Paper Test Could Make Drug Treatment Safer

Researchers looking to make tuberculosis (TB) and HIV treatment safer have developed a paper-based test for drug-induced liver damage.

Published
19 November 2012
From
Asian Scientist Magazine
New second generation combination therapy for HCV - first or best in the market

This article is Part 1 in a series about Hepatitis C intended to provide an update and fundamental analysis of the companies that are actively pursuing the development of an all oral therapy for HCV.

Published
19 November 2012
From
Seeking Alpha

Filter by country